Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; COVID-19 Vaccine Supplemental Medical Provider Statement, 16719-16721 [2022-06333]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 57 / Thursday, March 24, 2022 / Notices
to 5 p.m., and April 13, 2022, from 10
a.m. to 5 p.m. All meetings will be at
Eastern Standard Time.
ADDRESSES: Meeting address: The
hybrid meeting will be held at the
Courtyard Marriott Isla Verde Beach
Resort, 7012 Boca de Cangrejos,
Carolina, Puerto Rico, 00979.
You may join the SSC public hybrid
meeting via Zoom by entering the
following address: https://
us02web.zoom.us/j/87345855856?
pwd=SDc1V1NIK24xcEF0Zlhud0
lTNlcvdz09.
Meeting ID: 873 4585 5856.
Passcode: 793249.
One tap mobile:
+19399450244,,87345855856#,,,,
*793249# Puerto Rico
+17879451488,,87345855856#,,,,
*793249# Puerto Rico
Dial by your location:
+1 939 945 0244 Puerto Rico
+1 787 945 1488 Puerto Rico
+1 787 966 7727 Puerto Rico
+1 312 626 6799 U.S. (Chicago)
+1 346 248 7799 U.S. (Houston)
+1 646 558 8656 U.S. (New York)
+1 669 900 9128 U.S. (San Jose)
+1 253 215 8782 U.S. (Tacoma)
+1 301 715 8592 U.S. (Washington, DC)
Meeting ID: 873 4585 5856.
Passcode: 793249.
Find your local number: https://
us02web.zoom.us/u/kKUpZ2IPc.
In case there are problems and we
cannot reconnect via Zoom, the meeting
will continue via GoToMeeting. You
may join from a computer, tablet or
smartphone by entering the following
address: https://meet.goto.com/
474688061.
You can also dial in using your
phone.
United States: +1 (872) 240–3212
Access Code: 474–688–061
Join from a video-conferencing room
or system.
Dial in or type: 67.217.95.2 or
inroomlink.goto.com
Meeting ID: 474 688 061
Or dial directly: 474688061@
67.217.95.2 or 67.217.95.2##474688061.
Get the app now and be ready when
the first meeting starts: https://
meet.goto.com/install.
FOR FURTHER INFORMATION CONTACT:
Miguel Rolo´n, Executive Director,
Caribbean Fishery Management Council,
270 Mun˜oz Rivera Avenue, Suite 401,
San Juan, Puerto Rico 00918–1903,
telephone: (787) 398–3717.
SUPPLEMENTARY INFORMATION: The
following items included in the
tentative agenda will be discussed:
VerDate Sep<11>2014
17:39 Mar 23, 2022
Jkt 256001
April 12, 2022
10 a.m.–10:15 a.m.
—Call to order
—Roll call
—Approval of Verbatim Transcriptions
—Adoption of agenda
10:15 a.m.–12:30 p.m.
—Integrative analyses and visualization
of SEAMAP-Caribbean (SEAMAP–C)
data in Puerto Rico and the U.S.
Virgin Islands (aka The Gold Copy)—
JJ Cruz Motta
—Dashboard/Puerto Rico Port Sampling
and Catch Validation Project—Todd
Gedamke
—Discussion and Recommendations to
the CFMC
12:30 p.m.–1:30 p.m.
—Lunch
1:30 p.m.–3 p.m.
—Southeast Fishery Science Center
(SEFSC) Caribbean Branch Update
—SEFSC Inventory Update—Kevin
McCarthy and Rachel Eckley
—SSC Recommendations to CFMC
3 p.m.–3:15 p.m.
—Break
3:15 p.m.–5 p.m.
—SEDAR-Stock Assessment Matrix—
Kevin McCarthy, SEFSC
—Life history Update—Virginia
Shervette/Noemi Pen˜a/Jesus Rivera
—Continue discussion and
recommendations to CFMC
April 13, 2022
10 a.m.–12 p.m.
—Island-Based Fishery Management
Plan and Amendments Update—
Marı´a Lo´pez-Mercer, SERO/NOAA
Fisheries
—Updated OFLs/ABCs for spiny lobster
for years 2024–2026—SEFSC
—Update/SSC Review
—National SSC Update—Richard
Appeldoorn
—SSC Recommendations to CFMC
–Lunch
1 p.m.–3 p.m.
—Caribbean Fishery Management
Council’s (CFMC) 5-year Strategic
Plan—Michelle Duval
—Discussion: SSC Research Plan
Recommendations to CFMC
3 p.m.–3:15 p.m.
3:15 p.m.–5 p.m.
—Finalize Research Priorities and
Recommendations to CFMC
Fmt 4703
Special Accommodations
For any additional information on this
public virtual meeting, please contact
Dr. Graciela Garcı´a-Moliner, Caribbean
Fishery Management Council, 270
Mun˜oz Rivera Avenue, Suite 401, San
Juan, Puerto Rico 00918–1903,
telephone: (787) 403–8337.
Authority: 16 U.S.C. 1801 et seq.
Dated: March 21, 2022.
Tracey L. Thompson,
Acting Deputy Director, Office of Sustainable
Fisheries, National Marine Fisheries Service.
[FR Doc. 2022–06257 Filed 3–23–22; 8:45 am]
BILLING CODE 3510–22–P
DEPARTMENT OF COMMERCE
Agency Information Collection
Activities; Submission to the Office of
Management and Budget (OMB) for
Review and Approval; Comment
Request; COVID–19 Vaccine
Supplemental Medical Provider
Statement
United States Patent and
Trademark Office, Department of
Commerce.
ACTION: Notice of information collection;
request for comment.
AGENCY:
—Break
Frm 00016
—Ecosystem-Based Fishery
Management Technical Advisory
Panel (EBFM TAP) Update
—Sennai Habtes
—SSC Ecosystem Conceptual Model
review
—Where is it and how is it being used
—Lenfest overview (JJ Cruz Motta,
Stacey Williams, Tarsila Seara)
—Plan to Meld Conceptual Models—
Potentially Create Task Force—
Orian Tzadik
—DAPs ECM overview (Liajay Rivera)
—Ecosystem Status Report: Ecosystem
Indicators—Kelly Montenero,
Mandy Karnauskas, SEFSC
—SSC Recommendations to the
CFMC
—Other Business
—Adjourn
The order of business may be adjusted
as necessary to accommodate the
completion of agenda items. The
meeting will begin on April 12, 2022, at
10 a.m. EST, and will end on April 13,
2022, at 5 p.m. EST. Other than the start
time, interested parties should be aware
that discussions may start earlier or later
than indicated, at the discretion of the
Chair. In addition, the meeting may be
completed prior to the date established
in this notice.
United States Patent and Trademark
Office
12 p.m.–1 p.m.
PO 00000
16719
Sfmt 4703
E:\FR\FM\24MRN1.SGM
24MRN1
16720
Federal Register / Vol. 87, No. 57 / Thursday, March 24, 2022 / Notices
The United States Patent and
Trademark Office (USPTO), as required
by the Paperwork Reduction Act of
1995, invites comments on the
extension and revision of an existing
information collection: 0651–0087
(COVID–19 Vaccine Supplemental
Medical Provider Statement). The
purpose of this notice is to allow 60
days for public comment preceding
submission of the information collection
to OMB.
DATES: To ensure consideration,
comments regarding this information
collection must be received on or before
May 23, 2022.
ADDRESSES: Interested persons are
invited to submit written comments by
any of the following methods. Do not
submit Confidential Business
Information or otherwise sensitive or
protected information.
• Email: InformationCollection@
uspto.gov. Include ‘‘0651–0087
comment’’ in the subject line of the
message.
• Federal Rulemaking Portal: https://
www.regulations.gov.
• Mail: Kimberly Hardy, Office of the
Chief Administrative Officer, United
States Patent and Trademark Office,
P.O. Box 1450, Alexandria, VA 22313–
1450.
FOR FURTHER INFORMATION CONTACT:
Request for additional information
should be directed to Naveen Paul,
Office of Equal Employment
Opportunity and Diversity, United
States Patent and Trademark Office,
P.O. Box 1450, Alexandria, VA 22313–
1450; by telephone at 571–270–5395; or
by email at Naveen.Paul@uspto.gov
with ‘‘0651–0087 comment’’ in the
subject line. Additional information
about this information collection is also
available at https://www.reginfo.gov
under ‘‘Information Collection Review.’’
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Abstract
khammond on DSKJM1Z7X2PROD with NOTICES
Consistent with guidance from the
Centers for Disease Control and
Prevention (CDC), guidance from the
Safer Federal Workforce Task Force
established pursuant to E.O. 13991 of
January 20, 2021, Protecting the Federal
Workforce and Requiring Mask-Wearing,
and E.O. 14043 of September 9, 2021,
VerDate Sep<11>2014
17:39 Mar 23, 2022
Jkt 256001
Requiring Coronavirus Disease 2019
Vaccination for Federal Employees, the
request for this collection of information
is essential to implement the USPTO
health and safety measures regarding
the Federal employee medical
exemptions to the COVID–19 mandatory
vaccinations. The Rehabilitation Act of
1973, as amended, requires Federal
agencies to provide reasonable
accommodations to qualified employees
with disabilities unless that reasonable
accommodation would impose an
undue hardship on the employee’s
agency. See 29 U.S.C. 791; 29 CFR part
1614; see also 20 CFR part 1630 and
E.O.13164 of July 26, 2000, Requiring
Federal Agencies to Establish
Procedures to Facilitate the Provision of
Reasonable Accommodation. Section 2
of E.O. 14043 mandates that each
agency ‘‘implement, to the extent
consistent with applicable law, a
program to require COVID–19
vaccination for all of its Federal
employees, with exceptions only as
required by law.’’ This COVID–19
Vaccine Supplemental Medical Provider
Statement is necessary for USPTO to
determine legal exemptions to the
vaccine requirement under the
Rehabilitation Act.
The vaccination requirement issued
pursuant to E.O. 14043, is currently the
subject of a nationwide injunction.
While that injunction remains in place,
USPTO will not process requests for a
medical exception from the COVID–19
vaccination requirement pursuant to
E.O. 14043. USPTO will also not request
the submission of any medical
information related to a request for an
exception from the vaccination
requirement pursuant to E.O. 14043
while the injunction remains in place.
But USPTO may nevertheless receive
information regarding a medical
exception. That is because, if USPTO
were to receive a request for an
exception from the COVID–19
vaccination requirement pursuant to
E.O. 14043 during the pendency of the
injunction, USPTO will accept the
request, hold it in abeyance, and notify
the employee who submitted the request
that implementation and enforcement of
the COVID–19 vaccination requirement
pursuant to E.O. 14043 is currently
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
enjoined and that an exception therefore
is not necessary so long as the
injunction is in place. In other words,
during the pendency of the injunction,
any information collection related to
requests for medical exception from the
COVID–19 vaccination requirement
pursuant to E.O. 14043 is not
undertaken to implement or enforce the
COVID–19 vaccination requirement.
II. Method of Collection
USPTO utilizes its USPTO
Accommodation Point for employees to
request accommodations. The
individual responder/medical service
provider will fill out the required fields
of the form and submit the completed
form to the appropriate USPTO
personnel/employee requesting the
accommodation. A link to this form or
a PDF version may be emailed to
respondents who will then print it out
to complete it manually or complete it
electronically. USPTO will continue to
explore options to use technology to
reduce the burden on respondents.
III. Data
OMB Control Number: 0651–0087.
Forms:
• USPTO–OEEOD Form 303 (COVID–
19 Vaccine Supplemental Medical
Provider Statement)
Type of Review: Extension and
revision of a currently approved
information collection.
Affected Public: Private sector.
Respondent’s Obligation: Required to
obtain or retain benefits.
Estimated Number of Annual
Respondents: 150 respondents.
Estimated Number of Annual
Responses: 150 responses.
Estimated Time per Response: The
USPTO estimates that the responses in
this information collection will take the
public approximately 10 minutes (0.167
hours) to complete. This includes the
time to gather the necessary
information, create the document, and
submit the completed request to the
USPTO.
Estimated Total Annual Respondent
Burden Hours: 25 hours.
Estimated Total Annual Respondent
Hourly Cost Burden: $2,557.
E:\FR\FM\24MRN1.SGM
24MRN1
16721
Federal Register / Vol. 87, No. 57 / Thursday, March 24, 2022 / Notices
TABLE 1—TOTAL BURDEN HOURS AND HOURLY COSTS TO RESPONDENTS
Item No.
Item
1 .........................
Estimated
annual
respondents
Estimated
responses
per
respondent
Estimated
annual
responses
Estimated
time
for
response
(hour)
Estimated
burden
(hour/year)
Rate
($/hour)
Estimated
Annual
respondent
cost
burden
(a)
(b)
(a) × (b) = (c)
(d)
(c) × (d) = (e)
(f)
(e) × (f) = (g)
COVID–19 Vaccine Supplemental Medical Provider Statement.
150
1
150
0.167 (10 minutes).
25
$103.06
$2,577
Totals .......................
150
........................
150
............................
25
..................
2,577
Estimated Total Annual Respondent
Non-Hourly Cost Burden: $0. There are
no capital start-up, maintenance costs,
recordkeeping costs, filing fees, or
postage costs associated with this
information collection.
khammond on DSKJM1Z7X2PROD with NOTICES
IV. Request for Comments
Kimberly Hardy,
Information Collections Officer, Office of the
Chief Administrative Officer, United States
Patent and Trademark Office.
[FR Doc. 2022–06333 Filed 3–23–22; 8:45 am]
BILLING CODE 3510–16–P
17:39 Mar 23, 2022
National Nuclear Security
Administration
Defense Programs Advisory
Committee
Department of Energy, National
Nuclear Security Administration, Office
of Defense Programs.
ACTION: Notice of closed meeting.
AGENCY:
The USPTO is soliciting public
comments to:
(a) Evaluate whether the collection of
information is necessary for the proper
performance of the functions of the
Agency, including whether the
information will have practical utility;
(b) Evaluate the accuracy of the
Agency’s estimate of the burden of the
collection of information, including the
validity of the methodology and
assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; and
(d) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
All comments submitted in response
to this notice are a matter of public
record. USPTO will include or
summarize each comment in the request
to OMB to approve this information
collection. Before including an address,
phone number, email address, or other
personally identifiable information (PII)
in a comment, be aware that the entire
comment— including PII—may be made
publicly available at any time. While
you may ask in your comment to
withhold PII from public view, USPTO
cannot guarantee that it will be able to
do so.
VerDate Sep<11>2014
DEPARTMENT OF ENERGY
Jkt 256001
This notice announces a
closed meeting of the Defense Programs
Advisory Committee (DPAC). The
Federal Advisory Committee Act
requires that public notice of meetings
be announced in the Federal Register.
Due to national security considerations,
the meeting will be closed to the public
and matters to be discussed are exempt
from public disclosure under an
Executive Order, and the Atomic Energy
Act of 1954.
DATES: April 6, 2022; 1:00 p.m. to 4:00
p.m.
ADDRESSES: Microsoft Teams Video
Conferencing.
FOR FURTHER INFORMATION CONTACT: Ms.
Watti Hill, Office of Strategic
Partnership Programs (NA–10.1)
National Nuclear Security
Administration, U.S. Department of
Energy, 1000 Independence Ave. SW,
Washington, DC 20585, (202) 586–8266;
watti.hill@nnsa.doe.gov.
SUPPLEMENTARY INFORMATION:
Background: The DPAC provides
advice and recommendations to the
Deputy Administrator for Defense
Programs on topics related to Defense
Programs mission areas and those of the
National Nuclear Security
Administration.
Purpose of the Meeting: The Quarterly
meeting of the Defense Programs
Advisory Committee (DPAC) will cover
the current status of Committee
activities as well as additional charges
and is expected to contain discussions
of a sensitive nature.
Type of Meeting: In the interest of
national security, the meeting will be
closed to the public. The Federal
SUMMARY:
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
Advisory Committee Act, 5 U.S.C. App.
2, section 10(d), and the Federal
Advisory Committee Management
Regulation, 41 CFR 102–3.155,
incorporate by reference the
Government in the Sunshine Act, 5
U.S.C. 552b, which, at 552b(c)(1) and
(c)(3) permits closure of meetings where
restricted data or other classified
matters will be discussed.
Tentative Agenda: Welcome;
Headquarters and DPAC Updates;
discussion of reports and current
actions; discussion of next charges;
conclusion.
Public Participation: There will be no
public participation in this closed
meeting. Those wishing to provide
written comments or statements to the
Committee are invited to send them to
Ms. Watti Hill at the address listed
above.
Minutes: The minutes of the meeting
will not be available.
Signed in Washington, DC, on March 15,
2022.
LaTanya Butler,
Deputy Committee Management Officer.
[FR Doc. 2022–05860 Filed 3–23–22; 8:45 am]
BILLING CODE 6450–01–P
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
[Docket No. ER22–1370–000]
Sunlight Storage, LLC; Supplemental
Notice That Initial Market-Based Rate
Filing Includes Request for Blanket
Section 204 Authorization
This is a supplemental notice in the
above-referenced proceeding of Sunlight
Storage, LLC’s application for marketbased rate authority, with an
accompanying rate tariff, noting that
such application includes a request for
blanket authorization, under 18 CFR
part 34, of future issuances of securities
and assumptions of liability.
Any person desiring to intervene or to
protest should file with the Federal
Energy Regulatory Commission, 888
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 87, Number 57 (Thursday, March 24, 2022)]
[Notices]
[Pages 16719-16721]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06333]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
United States Patent and Trademark Office
Agency Information Collection Activities; Submission to the
Office of Management and Budget (OMB) for Review and Approval; Comment
Request; COVID-19 Vaccine Supplemental Medical Provider Statement
AGENCY: United States Patent and Trademark Office, Department of
Commerce.
ACTION: Notice of information collection; request for comment.
-----------------------------------------------------------------------
[[Page 16720]]
SUMMARY: The United States Patent and Trademark Office (USPTO), as
required by the Paperwork Reduction Act of 1995, invites comments on
the extension and revision of an existing information collection: 0651-
0087 (COVID-19 Vaccine Supplemental Medical Provider Statement). The
purpose of this notice is to allow 60 days for public comment preceding
submission of the information collection to OMB.
DATES: To ensure consideration, comments regarding this information
collection must be received on or before May 23, 2022.
ADDRESSES: Interested persons are invited to submit written comments by
any of the following methods. Do not submit Confidential Business
Information or otherwise sensitive or protected information.
Email: [email protected]. Include ``0651-
0087 comment'' in the subject line of the message.
Federal Rulemaking Portal: https://www.regulations.gov.
Mail: Kimberly Hardy, Office of the Chief Administrative
Officer, United States Patent and Trademark Office, P.O. Box 1450,
Alexandria, VA 22313-1450.
FOR FURTHER INFORMATION CONTACT: Request for additional information
should be directed to Naveen Paul, Office of Equal Employment
Opportunity and Diversity, United States Patent and Trademark Office,
P.O. Box 1450, Alexandria, VA 22313-1450; by telephone at 571-270-5395;
or by email at [email protected] with ``0651-0087 comment'' in the
subject line. Additional information about this information collection
is also available at https://www.reginfo.gov under ``Information
Collection Review.''
SUPPLEMENTARY INFORMATION:
I. Abstract
Consistent with guidance from the Centers for Disease Control and
Prevention (CDC), guidance from the Safer Federal Workforce Task Force
established pursuant to E.O. 13991 of January 20, 2021, Protecting the
Federal Workforce and Requiring Mask-Wearing, and E.O. 14043 of
September 9, 2021, Requiring Coronavirus Disease 2019 Vaccination for
Federal Employees, the request for this collection of information is
essential to implement the USPTO health and safety measures regarding
the Federal employee medical exemptions to the COVID-19 mandatory
vaccinations. The Rehabilitation Act of 1973, as amended, requires
Federal agencies to provide reasonable accommodations to qualified
employees with disabilities unless that reasonable accommodation would
impose an undue hardship on the employee's agency. See 29 U.S.C. 791;
29 CFR part 1614; see also 20 CFR part 1630 and E.O.13164 of July 26,
2000, Requiring Federal Agencies to Establish Procedures to Facilitate
the Provision of Reasonable Accommodation. Section 2 of E.O. 14043
mandates that each agency ``implement, to the extent consistent with
applicable law, a program to require COVID-19 vaccination for all of
its Federal employees, with exceptions only as required by law.'' This
COVID-19 Vaccine Supplemental Medical Provider Statement is necessary
for USPTO to determine legal exemptions to the vaccine requirement
under the Rehabilitation Act.
The vaccination requirement issued pursuant to E.O. 14043, is
currently the subject of a nationwide injunction. While that injunction
remains in place, USPTO will not process requests for a medical
exception from the COVID-19 vaccination requirement pursuant to E.O.
14043. USPTO will also not request the submission of any medical
information related to a request for an exception from the vaccination
requirement pursuant to E.O. 14043 while the injunction remains in
place. But USPTO may nevertheless receive information regarding a
medical exception. That is because, if USPTO were to receive a request
for an exception from the COVID-19 vaccination requirement pursuant to
E.O. 14043 during the pendency of the injunction, USPTO will accept the
request, hold it in abeyance, and notify the employee who submitted the
request that implementation and enforcement of the COVID-19 vaccination
requirement pursuant to E.O. 14043 is currently enjoined and that an
exception therefore is not necessary so long as the injunction is in
place. In other words, during the pendency of the injunction, any
information collection related to requests for medical exception from
the COVID-19 vaccination requirement pursuant to E.O. 14043 is not
undertaken to implement or enforce the COVID-19 vaccination
requirement.
II. Method of Collection
USPTO utilizes its USPTO Accommodation Point for employees to
request accommodations. The individual responder/medical service
provider will fill out the required fields of the form and submit the
completed form to the appropriate USPTO personnel/employee requesting
the accommodation. A link to this form or a PDF version may be emailed
to respondents who will then print it out to complete it manually or
complete it electronically. USPTO will continue to explore options to
use technology to reduce the burden on respondents.
III. Data
OMB Control Number: 0651-0087.
Forms:
USPTO-OEEOD Form 303 (COVID-19 Vaccine Supplemental
Medical Provider Statement)
Type of Review: Extension and revision of a currently approved
information collection.
Affected Public: Private sector.
Respondent's Obligation: Required to obtain or retain benefits.
Estimated Number of Annual Respondents: 150 respondents.
Estimated Number of Annual Responses: 150 responses.
Estimated Time per Response: The USPTO estimates that the responses
in this information collection will take the public approximately 10
minutes (0.167 hours) to complete. This includes the time to gather the
necessary information, create the document, and submit the completed
request to the USPTO.
Estimated Total Annual Respondent Burden Hours: 25 hours.
Estimated Total Annual Respondent Hourly Cost Burden: $2,557.
[[Page 16721]]
Table 1--Total Burden Hours and Hourly Costs to Respondents
--------------------------------------------------------------------------------------------------------------------------------------------------------
Estimated
Estimated Estimated Estimated Estimated time for Estimated Rate ($/ Annual
Item No. Item annual responses per annual response (hour) burden (hour/ hour) respondent
respondents respondent responses year) cost burden
(a) (b) (a) x (b) = (d)................ (c) x (d) = (f) (e) x (f) =
(c) (e) (g)
--------------------------------------------------------------------------------------------------------------------------------------------------------
1................... COVID-19 Vaccine 150 1 150 0.167 (10 minutes). 25 $103.06 $2,577
Supplemental
Medical Provider
Statement.
----------------------------------------------------------------------------------------------------------------
Totals........ 150 .............. 150 ................... 25 .......... 2,577
--------------------------------------------------------------------------------------------------------------------------------------------------------
Estimated Total Annual Respondent Non-Hourly Cost Burden: $0. There
are no capital start-up, maintenance costs, recordkeeping costs, filing
fees, or postage costs associated with this information collection.
IV. Request for Comments
The USPTO is soliciting public comments to:
(a) Evaluate whether the collection of information is necessary for
the proper performance of the functions of the Agency, including
whether the information will have practical utility;
(b) Evaluate the accuracy of the Agency's estimate of the burden of
the collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected; and
(d) Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
All comments submitted in response to this notice are a matter of
public record. USPTO will include or summarize each comment in the
request to OMB to approve this information collection. Before including
an address, phone number, email address, or other personally
identifiable information (PII) in a comment, be aware that the entire
comment-- including PII--may be made publicly available at any time.
While you may ask in your comment to withhold PII from public view,
USPTO cannot guarantee that it will be able to do so.
Kimberly Hardy,
Information Collections Officer, Office of the Chief Administrative
Officer, United States Patent and Trademark Office.
[FR Doc. 2022-06333 Filed 3-23-22; 8:45 am]
BILLING CODE 3510-16-P
